Blood Plasma Fractionation Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Blood Plasma Fractionation Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Blood Plasma Fractionation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Blood Plasma Fractionation Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Blood Plasma Fractionation companies in 2021 (%)
The global Blood Plasma Fractionation market was valued at 29140 million in 2021 and is projected to reach US$ 47720 million by 2028, at a CAGR of 7.3% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune Globulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Blood Plasma Fractionation manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Blood Plasma Fractionation Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Blood Plasma Fractionation Market Segment Percentages, by Type, 2021 (%)
Immune Globulin
Coagulation Factor
Albumin
Other
Global Blood Plasma Fractionation Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Blood Plasma Fractionation Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Blood Plasma Fractionation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Blood Plasma Fractionation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Plasma Fractionation revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Blood Plasma Fractionation revenues share in global market, 2021 (%)
Key companies Blood Plasma Fractionation sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Blood Plasma Fractionation sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Blood Plasma Fractionation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Plasma Fractionation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Plasma Fractionation Overall Market Size
2.1 Global Blood Plasma Fractionation Market Size: 2021 VS 2028
2.2 Global Blood Plasma Fractionation Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Blood Plasma Fractionation Sales: 2017-2028
3 Company Landscape
3.1 Top Blood Plasma Fractionation Players in Global Market
3.2 Top Global Blood Plasma Fractionation Companies Ranked by Revenue
3.3 Global Blood Plasma Fractionation Revenue by Companies
3.4 Global Blood Plasma Fractionation Sales by Companies
3.5 Global Blood Plasma Fractionation Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Blood Plasma Fractionation Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Blood Plasma Fractionation Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blood Plasma Fractionation Players in Global Market
3.8.1 List of Global Tier 1 Blood Plasma Fractionation Companies
3.8.2 List of Global Tier 2 and Tier 3 Blood Plasma Fractionation Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Blood Plasma Fractionation Market Size Markets, 2021 & 2028
4.1.2 Immune Globulin
4.1.3 Coagulation Factor
4.1.4 Albumin
4.1.5 Other
4.2 By Type - Global Blood Plasma Fractionation Revenue & Forecasts
4.2.1 By Type - Global Blood Plasma Fractionation Revenue, 2017-2022
4.2.2 By Type - Global Blood Plasma Fractionation Revenue, 2023-2028
4.2.3 By Type - Global Blood Plasma Fractionation Revenue Market Share, 2017-2028
4.3 By Type - Global Blood Plasma Fractionation Sales & Forecasts
4.3.1 By Type - Global Blood Plasma Fractionation Sales, 2017-2022
4.3.2 By Type - Global Blood Plasma Fractionation Sales, 2023-2028
4.3.3 By Type - Global Blood Plasma Fractionation Sales Market Share, 2017-2028
4.4 By Type - Global Blood Plasma Fractionation Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Blood Plasma Fractionation Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Blood Plasma Fractionation Revenue & Forecasts
5.2.1 By Application - Global Blood Plasma Fractionation Revenue, 2017-2022
5.2.2 By Application - Global Blood Plasma Fractionation Revenue, 2023-2028
5.2.3 By Application - Global Blood Plasma Fractionation Revenue Market Share, 2017-2028
5.3 By Application - Global Blood Plasma Fractionation Sales & Forecasts
5.3.1 By Application - Global Blood Plasma Fractionation Sales, 2017-2022
5.3.2 By Application - Global Blood Plasma Fractionation Sales, 2023-2028
5.3.3 By Application - Global Blood Plasma Fractionation Sales Market Share, 2017-2028
5.4 By Application - Global Blood Plasma Fractionation Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Blood Plasma Fractionation Market Size, 2021 & 2028
6.2 By Region - Global Blood Plasma Fractionation Revenue & Forecasts
6.2.1 By Region - Global Blood Plasma Fractionation Revenue, 2017-2022
6.2.2 By Region - Global Blood Plasma Fractionation Revenue, 2023-2028
6.2.3 By Region - Global Blood Plasma Fractionation Revenue Market Share, 2017-2028
6.3 By Region - Global Blood Plasma Fractionation Sales & Forecasts
6.3.1 By Region - Global Blood Plasma Fractionation Sales, 2017-2022
6.3.2 By Region - Global Blood Plasma Fractionation Sales, 2023-2028
6.3.3 By Region - Global Blood Plasma Fractionation Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Blood Plasma Fractionation Revenue, 2017-2028
6.4.2 By Country - North America Blood Plasma Fractionation Sales, 2017-2028
6.4.3 US Blood Plasma Fractionation Market Size, 2017-2028
6.4.4 Canada Blood Plasma Fractionation Market Size, 2017-2028
6.4.5 Mexico Blood Plasma Fractionation Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Blood Plasma Fractionation Revenue, 2017-2028
6.5.2 By Country - Europe Blood Plasma Fractionation Sales, 2017-2028
6.5.3 Germany Blood Plasma Fractionation Market Size, 2017-2028
6.5.4 France Blood Plasma Fractionation Market Size, 2017-2028
6.5.5 U.K. Blood Plasma Fractionation Market Size, 2017-2028
6.5.6 Italy Blood Plasma Fractionation Market Size, 2017-2028
6.5.7 Russia Blood Plasma Fractionation Market Size, 2017-2028
6.5.8 Nordic Countries Blood Plasma Fractionation Market Size, 2017-2028
6.5.9 Benelux Blood Plasma Fractionation Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Blood Plasma Fractionation Revenue, 2017-2028
6.6.2 By Region - Asia Blood Plasma Fractionation Sales, 2017-2028
6.6.3 China Blood Plasma Fractionation Market Size, 2017-2028
6.6.4 Japan Blood Plasma Fractionation Market Size, 2017-2028
6.6.5 South Korea Blood Plasma Fractionation Market Size, 2017-2028
6.6.6 Southeast Asia Blood Plasma Fractionation Market Size, 2017-2028
6.6.7 India Blood Plasma Fractionation Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Blood Plasma Fractionation Revenue, 2017-2028
6.7.2 By Country - South America Blood Plasma Fractionation Sales, 2017-2028
6.7.3 Brazil Blood Plasma Fractionation Market Size, 2017-2028
6.7.4 Argentina Blood Plasma Fractionation Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Blood Plasma Fractionation Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Blood Plasma Fractionation Sales, 2017-2028
6.8.3 Turkey Blood Plasma Fractionation Market Size, 2017-2028
6.8.4 Israel Blood Plasma Fractionation Market Size, 2017-2028
6.8.5 Saudi Arabia Blood Plasma Fractionation Market Size, 2017-2028
6.8.6 UAE Blood Plasma Fractionation Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Takeda
7.1.1 Takeda Corporate Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Blood Plasma Fractionation Major Product Offerings
7.1.4 Takeda Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Blood Plasma Fractionation Major Product Offerings
7.2.4 CSL Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.2.5 CSL Key News
7.3 Grifols
7.3.1 Grifols Corporate Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Blood Plasma Fractionation Major Product Offerings
7.3.4 Grifols Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.3.5 Grifols Key News
7.4 Octapharma
7.4.1 Octapharma Corporate Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Blood Plasma Fractionation Major Product Offerings
7.4.4 Octapharma Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.4.5 Octapharma Key News
7.5 Kedrion
7.5.1 Kedrion Corporate Summary
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Blood Plasma Fractionation Major Product Offerings
7.5.4 Kedrion Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.5.5 Kedrion Key News
7.6 LFB Group
7.6.1 LFB Group Corporate Summary
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Blood Plasma Fractionation Major Product Offerings
7.6.4 LFB Group Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.6.5 LFB Group Key News
7.7 Biotest
7.7.1 Biotest Corporate Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Blood Plasma Fractionation Major Product Offerings
7.7.4 Biotest Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.7.5 Biotest Key News
7.8 BPL
7.8.1 BPL Corporate Summary
7.8.2 BPL Business Overview
7.8.3 BPL Blood Plasma Fractionation Major Product Offerings
7.8.4 BPL Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.8.5 BPL Key News
7.9 RAAS
7.9.1 RAAS Corporate Summary
7.9.2 RAAS Business Overview
7.9.3 RAAS Blood Plasma Fractionation Major Product Offerings
7.9.4 RAAS Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.9.5 RAAS Key News
7.10 CBPO
7.10.1 CBPO Corporate Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Blood Plasma Fractionation Major Product Offerings
7.10.4 CBPO Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.10.5 CBPO Key News
7.11 Hualan Bio
7.11.1 Hualan Bio Corporate Summary
7.11.2 Hualan Bio Blood Plasma Fractionation Business Overview
7.11.3 Hualan Bio Blood Plasma Fractionation Major Product Offerings
7.11.4 Hualan Bio Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.11.5 Hualan Bio Key News
7.12 Tiantan Bio
7.12.1 Tiantan Bio Corporate Summary
7.12.2 Tiantan Bio Blood Plasma Fractionation Business Overview
7.12.3 Tiantan Bio Blood Plasma Fractionation Major Product Offerings
7.12.4 Tiantan Bio Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.12.5 Tiantan Bio Key News
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Corporate Summary
7.13.2 Shuanglin Bio Blood Plasma Fractionation Business Overview
7.13.3 Shuanglin Bio Blood Plasma Fractionation Major Product Offerings
7.13.4 Shuanglin Bio Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.13.5 Shuanglin Bio Key News
7.14 Boya Bio
7.14.1 Boya Bio Corporate Summary
7.14.2 Boya Bio Business Overview
7.14.3 Boya Bio Blood Plasma Fractionation Major Product Offerings
7.14.4 Boya Bio Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.14.5 Boya Bio Key News
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Corporate Summary
7.15.2 Yuanda Shuyang Business Overview
7.15.3 Yuanda Shuyang Blood Plasma Fractionation Major Product Offerings
7.15.4 Yuanda Shuyang Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.15.5 Yuanda Shuyang Key News
7.16 Weiguang Bio
7.16.1 Weiguang Bio Corporate Summary
7.16.2 Weiguang Bio Business Overview
7.16.3 Weiguang Bio Blood Plasma Fractionation Major Product Offerings
7.16.4 Weiguang Bio Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.16.5 Weiguang Bio Key News
7.17 Nanyue Bio
7.17.1 Nanyue Bio Corporate Summary
7.17.2 Nanyue Bio Business Overview
7.17.3 Nanyue Bio Blood Plasma Fractionation Major Product Offerings
7.17.4 Nanyue Bio Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.17.5 Nanyue Bio Key News
7.18 KM Biologics
7.18.1 KM Biologics Corporate Summary
7.18.2 KM Biologics Business Overview
7.18.3 KM Biologics Blood Plasma Fractionation Major Product Offerings
7.18.4 KM Biologics Blood Plasma Fractionation Sales and Revenue in Global (2017-2022)
7.18.5 KM Biologics Key News
8 Global Blood Plasma Fractionation Production Capacity, Analysis
8.1 Global Blood Plasma Fractionation Production Capacity, 2017-2028
8.2 Blood Plasma Fractionation Production Capacity of Key Manufacturers in Global Market
8.3 Global Blood Plasma Fractionation Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blood Plasma Fractionation Supply Chain Analysis
10.1 Blood Plasma Fractionation Industry Value Chain
10.2 Blood Plasma Fractionation Upstream Market
10.3 Blood Plasma Fractionation Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blood Plasma Fractionation Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Blood Plasma Fractionation Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|